(Q30860178)

27 June 2017

title

Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema (English)

1 reference

27 June 2017

0 references

Heyer G

1

1 reference

27 June 2017

Groene D

series ordinal

2

1 reference

27 June 2017

Martus P

series ordinal

3

1 reference

27 June 2017

publication date

1 October 2002

1 reference

27 June 2017

published in

Experimental Dermatology

1 reference

27 June 2017

volume

11

1 reference

27 June 2017

issue

5

1 reference

27 June 2017

page(s)

448-455

1 reference

Recent studies of cutaneous nociception in atopic and non-atopic subjects

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Cutaneous reactions and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Skin, immunity and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

delta 1-Opioid receptor-mediated control of acetylcholine (ACh) release in human neocortex slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Naloxone modulates the perception of itch in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Human keratinocytes synthesize, secrete, and degrade acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Opiate antagonists in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Inhibition of passive cutaneous anaphylaxis-associated scratching behavior by mu-opioid receptor antagonists in ICR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Modern hair restoration surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Calcitonin gene-related peptide is a potent vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

A neural pathway for itch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Itch and atopic dermatitis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Which nerve fibers mediate the axon reflex flare in human skin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

A controlled trial of naloxone infusions for the pruritus of chronic cholestasis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Randomised crossover trial of naltrexone in uraemic pruritus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33-824, ?-endorphin and morphine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Enkephalins modulate differentiation of normal human keratinocytes in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Acetylcholine in normal and diseased skin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Depression modulates pruritus perception. A study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

Psychophysiological analysis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2002.110508.X

7 January 2021

10.1034/J.1600-0625.2002.110508.X

Identifiers

DOI

1 reference

27 June 2017

1 reference